{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:27:43Z","timestamp":1793237263375,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.spen.2024.101172","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T20:27:15Z","timestamp":1731443235000},"page":"101172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Neurofibromatosis type 1 - an update"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5998-0371","authenticated-orcid":false,"given":"Manikum","family":"Moodley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla Robles","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2024.101172_bib0001","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/09647041003642885","article-title":"A history of von Recklinghausen's NF1","volume":"19","author":"Brosius","year":"2010","journal-title":"J Hist Neurosci"},{"key":"10.1016\/j.spen.2024.101172_bib0002","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1590\/abd1806-4841.20132125","article-title":"Neurofibromatosis: chronological history and current issues","volume":"88","author":"Ant\u00f4nio","year":"2013","journal-title":"An Bras Dermatol"},{"issue":"2","key":"10.1016\/j.spen.2024.101172_bib0003","article-title":"RAS and beyond: the many faces of the neurofibromatosis type 1 protein","volume":"15","author":"Anastasaki","year":"2022","journal-title":"DMM Dis Model Mech"},{"key":"10.1016\/j.spen.2024.101172_bib0004","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.gim.2022.05.007","article-title":"Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: an international consensus recommendation","volume":"24","author":"Plotkin","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.spen.2024.101172_bib0005","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1542\/peds.2007-3364","article-title":"Health supervision for children with neurofibromatosis","volume":"121","author":"Hersh","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2024.101172_bib0006","doi-asserted-by":"crossref","first-page":"073","DOI":"10.1055\/s-0038-1627471","article-title":"Neurofibromatosis and schwannomatosis","volume":"38","author":"Plotkin","year":"2018","journal-title":"Semin Neurol"},{"key":"10.1016\/j.spen.2024.101172_bib0007","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archderm.141.1.71","article-title":"Prevalence of neurofibromatosis 1 in German children at elementary school enrollment","volume":"141","author":"Lammert","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.spen.2024.101172_bib0008","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.spen.2024.101172_bib0009","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00439-021-02410-z","article-title":"Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants","volume":"141","author":"Kehrer-Sawatzki","year":"2022","journal-title":"Hum Genet"},{"key":"10.1016\/j.spen.2024.101172_bib0010","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.pcl.2010.07.002","article-title":"The diagnostic and clinical significance of Caf\u00e9-au-lait Macules","volume":"57","author":"Shah","year":"2010","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.spen.2024.101172_bib0011","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1542\/peds.105.3.608","article-title":"Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children","volume":"105","author":"DeBella","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2024.101172_bib0012","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pedhc.2019.05.001","article-title":"Caf\u00e9 au lait macules and associated genetic syndromes","volume":"34","author":"Anderson","year":"2020","journal-title":"J Pediatr Heal Care"},{"key":"10.1016\/j.spen.2024.101172_bib0013","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1212\/WNL.0000000000005792","article-title":"Cutaneous neurofibromas: current clinical and pathologic issues","volume":"91","author":"Ortonne","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2024.101172_bib0014","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1590\/1678-4685-gmb-2015-0024","article-title":"Prevalence of Caf\u00e9-au-Lait spots in children with solid tumors","volume":"39","author":"Santos","year":"2016","journal-title":"Genet Mol Biol"},{"issue":"2","key":"10.1016\/j.spen.2024.101172_bib0015","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/bjd\/ljad390","article-title":"Identification of potential common genetic modifiers of neurofibromas: a genome-wide association study in 1333 patients with neurofibromatosis type 1","volume":"190","author":"Pacot","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.spen.2024.101172_bib0016","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/ajmg.a.32301","article-title":"The role of steroid hormones in the NF1 phenotype: focus on pregnancy","volume":"146A","author":"Roth","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.spen.2024.101172_bib0017","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jpeds.2011.08.051","article-title":"Pediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1","volume":"160","author":"Prada","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.spen.2024.101172_bib0018","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00431-013-2035-2","article-title":"Ophthalmological assessment of children with neurofibromatosis type 1","volume":"172","author":"Cassiman","year":"2013","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.spen.2024.101172_bib0019","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1167\/iovs.09-3650","article-title":"A quantitative assessment of the burden and distribution of lisch nodules in adults with neurofibromatosis type 1","volume":"50","author":"Boley","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.spen.2024.101172_bib0020","first-page":"152","article-title":"Neurofibrosarcoma as a complication of von Recklinghausen neurofibromatosis","volume":"2","author":"Riccardi","year":"1989","journal-title":"Neurofibromatosis"},{"key":"10.1016\/j.spen.2024.101172_bib0021","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/(SICI)1096-8628(19991203)87:4<317::AID-AJMG7>3.0.CO;2-X","article-title":"Neurofibromatosis type 1 growth charts","volume":"87","author":"Clementi","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.spen.2024.101172_bib0022","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1007\/s00381-020-04697-1","article-title":"Neurofibromatosis 1\u2013associated optic pathway gliomas","volume":"36","author":"Shofty","year":"2020","journal-title":"Child's Nerv Syst"},{"key":"10.1016\/j.spen.2024.101172_bib0023","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ocl.2007.03.008","article-title":"Scoliosis associated with neurofibromatosis","volume":"38","author":"Crawford","year":"2007","journal-title":"Orthop Clin North Am"},{"key":"10.1016\/j.spen.2024.101172_bib0024","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3476(94)70122-9","article-title":"Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study","volume":"125","author":"Listernick","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.spen.2024.101172_bib0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13023-018-0811-9","article-title":"Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1","volume":"13","author":"Sellmer","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.spen.2024.101172_bib0026","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/jbmr.1685","article-title":"A controlled register-based study of 460 neurofibromatosis 1 patients: increased fracture risk in children and adults over 41 years of age","volume":"27","author":"Heerv\u00e4","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.spen.2024.101172_bib0027","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.spen.2024.101172_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121838","article-title":"Risk of optic pathway glioma in neurofibromatosis type 1: No evidence of genotype-phenotype correlations in A large independent cohort","volume":"11","author":"Melloni","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.spen.2024.101172_bib0029","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","article-title":"Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective","volume":"6","author":"Ferner","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2024.101172_bib0030","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajpath.2010.10.041","article-title":"The development of cutaneous neurofibromas","volume":"178","author":"Jouhilahti","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.spen.2024.101172_bib0031","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2350-13-98","article-title":"Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions","volume":"13","author":"Mu\u00dfotter","year":"2012","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.spen.2024.101172_bib0032","first-page":"1","article-title":"Impacts of NF1 gene mutations and genetic modifiers in neurofibromatosis type 1","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.spen.2024.101172_bib0033","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1086\/498454","article-title":"NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome","volume":"77","author":"De Luca","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2024.101172_bib0034","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s00381-020-04711-6","article-title":"The value of screening tests in children with neurofibromatosis type 1 (NF1)","volume":"36","author":"Baudou","year":"2020","journal-title":"Child's Nerv Syst"},{"key":"10.1016\/j.spen.2024.101172_bib0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev-pathol-052016-100228","article-title":"Dissecting clinical heterogeneity in neurofibromatosis type 1","volume":"12","author":"Monroe","year":"2017","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"10.1016\/j.spen.2024.101172_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/431029","article-title":"Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with neurofibromatosis type 1: A systematic review","volume":"2012","author":"Treglia","year":"2012","journal-title":"Radiol Res Pract"},{"key":"10.1016\/j.spen.2024.101172_bib0037","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejso.2012.09.001","article-title":"Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location","volume":"39","author":"Kamran","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.spen.2024.101172_bib0038","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13023-020-1310-3","article-title":"Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966","volume":"15","author":"Bergqvist","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.spen.2024.101172_bib0039","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1212\/01.WNL.0000150544.00016.69","article-title":"Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1","volume":"64","author":"Rosser","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2024.101172_bib0040","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1542\/peds.104.4.e49","article-title":"Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential?","volume":"104","author":"Griffiths","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2024.101172_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2019.01373","article-title":"Can the cognitive phenotype in neurofibromatosis type 1 (NF1) Be explained by neuroimaging ?","volume":"10","author":"Baudou","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.spen.2024.101172_bib0042","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15072109","article-title":"Evaluating focal areas of signal intensity (FASI) in children with neurofibromatosis type-1 (NF1) treated with Selumetinib on pediatric brain tumor consortium (PBTC)-029B","volume":"15","author":"Pillay-Smiley","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.spen.2024.101172_bib0043","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1523\/JNEUROSCI.13-04-01588.1993","article-title":"Neurofibromin is enriched in the endoplasmic reticulum of CNS neurons","volume":"13","author":"Nordlund","year":"1993","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"10.1016\/j.spen.2024.101172_bib0044","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4274\/balkanmedj.galenos.2023.2022-12-28","article-title":"Mutational spectrum and genotype-phenotype correlations in neurofibromatosis type 1 patients from North Macedonia: identification of ten novel NF1 pathogenic variants","volume":"40","author":"Gjorgjievska","year":"2023","journal-title":"Balkan Med J"},{"key":"10.1016\/j.spen.2024.101172_bib0045","doi-asserted-by":"crossref","unstructured":"Wang, W., Wei, C., Cui, X., et al. (2021). Impacts of NF1 gene mutations and genetic modifiers in neurofibromatosis type 1. 12, 1\u201312. https:\/\/doi.org\/10.3389\/fneur.2021.704639.","DOI":"10.3389\/fneur.2021.704639"},{"key":"10.1016\/j.spen.2024.101172_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/genes12101639","article-title":"Atypical nf1 microdeletions: challenges and opportunities for genotype\/phenotype correlations in patients with large nf1 deletions","volume":"12","author":"Kehrer-Sawatzki","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.spen.2024.101172_bib0047","first-page":"273","article-title":"The NF1 microdeletion syndrome: early genetic diagnosis facilitates the management of a clinically defined disease","volume":"20","author":"Kehrer-Sawatzki","year":"2022","journal-title":"JDDG - J Ger Soc Dermatology"},{"key":"10.1016\/j.spen.2024.101172_bib0048","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/ng0293-122","article-title":"Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis","volume":"3","author":"Legius","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.spen.2024.101172_bib0049","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(09)70033-6","article-title":"Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1","volume":"10","author":"Brems","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.spen.2024.101172_bib0050","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s11916-024-01283-x","article-title":"Pain related quality of life in neurofibromatosis type 1: A narrative review","volume":"11","author":"Stech","year":"2024","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.spen.2024.101172_bib0051","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1152\/jn.01010.2009","article-title":"Augmented sodium currents contribute to the enhanced excitability of small diameter capsaicin-sensitive sensory neurons isolated from Nf1+\/\u2212 mice","volume":"103","author":"Wang","year":"2010","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.spen.2024.101172_bib0052","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1111\/bph.13737","article-title":"Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides","volume":"175","author":"Moutal","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.spen.2024.101172_bib0053","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neulet.2011.03.083","article-title":"Ras signaling pathways mediate NGF-induced enhancement of excitability of small-diameter capsaicin-sensitive sensory neurons from wildtype but not Nf1\u00b1 mice","volume":"496","author":"Duan","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.spen.2024.101172_bib0054","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1007\/s00381-020-04731-2","article-title":"Current status of MEK inhibitors in the treatment of plexiform neurofibromas","volume":"36","author":"Gross","year":"2020","journal-title":"Child's Nerv Syst"},{"key":"10.1016\/j.spen.2024.101172_bib0055","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/ajmg.a.36466","article-title":"Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis","volume":"164A","author":"Merker","year":"2014","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.spen.2024.101172_bib0056","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000337548","article-title":"Psychological burden in adult neurofibromatosis type 1 patients: impact of disease visibility on body image","volume":"224","author":"Granstr\u00f6m","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.spen.2024.101172_bib0057","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejpn.2020.07.014","article-title":"Cognitive functioning and pain interference mediate pain predictive effects on health-related quality of life in pediatric patients with Neurofibromatosis type 1","volume":"28","author":"Varni","year":"2020","journal-title":"Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc"},{"key":"10.1016\/j.spen.2024.101172_bib0058","doi-asserted-by":"crossref","first-page":"e1109","DOI":"10.1634\/theoncologist.2020-0069","article-title":"The use of MEK inhibitors in neurofibromatosis type 1 \u2013 Associated tumors and management of toxicities","volume":"25","author":"Klesse","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.spen.2024.101172_bib0059","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/10409238.2012.694846","article-title":"Suppression of premature termination codons as a therapeutic approach","volume":"47","author":"Keeling","year":"2012","journal-title":"Crit Rev Biochem Mol Biol"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909124000585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909124000585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T15:19:27Z","timestamp":1732979967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909124000585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":59,"alternative-id":["S1071909124000585"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2024.101172","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofibromatosis type 1 - an update","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2024.101172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101172"}}